Application effect of furosemide combined with vasoactive drugs in cardio-renal syndrome: a systematic review

Lang WANG,Bo YANG,Xin QI,Xi-juan JIANG,Xiao-li PANG,Mao-juan GUO

DOI: https://doi.org/10.13329/j.cnki.zyyjk.2018.0116

2018-01-01

Abstract:[Objective] To systematically evaluate the effect of furosemide combined with vasoactive drugs in cardio-renal syndrome.[Methods] A computerized search in PubMed,Embase,CENTRAL,Web of Science,CBM,CNKI and Wanfang Database was performed for randomized controlled trials(RCTs) which studied the effects of furosemide combined with other drugs in the treatment of cardio-renal syndrome.According to the inclusion and exclusion criteria,the literatures were selected.And,RevMan5.3 software was used for meta analysis.[Results] A total of 10 RCTs involving 934 patients with cardio-renal syndrome were included.The observation group was given the drug intervention for low dose furosemide combined with low dose of dopamine and other drugs for the treatment of heart failure.The results of meta analysis showed that the observation group therapy reduced the serum creatinine in patients with type Ⅰ and Ⅱ cardio-renal syndrome [MD =-36.00,95％CI(-39.75,-32.24),P＜0.05],increase the left ventricular ejection fraction in patients with type Ⅱ cardio-reual syndrome [MD=5.47,95％ CI (4.69,6.25),P＜0.05],and increaseg 6 min walking distance in patients with type Ⅱ cardio-renal syndrome [MD=36.22,95％CI (29.24,43.20),P＜0.05],which had better clinical curative effect [RR=1.27,95％CI (1.08,1.49),P＜0.05].[Conclusion] Low dose of furosemide and dopamine therapy can effectively improve the cardiac function and renal function,and it has better therapeutic effect on type Ⅱ cardio-renal syndrome.The therapy has some effect on type Ⅰ cardio-renal syndrome,but there is insufficient evidence.The effect of type Ⅲ,Ⅳ and Ⅴ cardio-renal syndrome is uncertain,which needs further verification.